366 related articles for article (PubMed ID: 10958254)
1. A randomized, double-blind, parallel-group comparison of venlafaxine and clomipramine in outpatients with major depression.
Samuelian JC; Hackett D
J Psychopharmacol; 1998; 12(3):273-8. PubMed ID: 10958254
[TBL] [Abstract][Full Text] [Related]
2. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia.
Gentil V; Kerr-Correa F; Moreno R; D'Arrigo Busnello E; De Campos JA; Juruena MF; Lafer B; Moreno DH; De Cassia Rodrigues RL; Tiosso A; Benedictis E
J Psychopharmacol; 2000 Mar; 14(1):61-6. PubMed ID: 10757255
[TBL] [Abstract][Full Text] [Related]
3. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
Guelfi JD; Ansseau M; Timmerman L; Kørsgaard S;
J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
[TBL] [Abstract][Full Text] [Related]
4. A randomised, double-blind, parallel-group comparison of venlafaxine and dothiepin in geriatric patients with major depression.
Mahapatra SN; Hackett D
Int J Clin Pract; 1997 Jun; 51(4):209-13. PubMed ID: 9287259
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
Thase ME
J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
Ballús C; Quiros G; De Flores T; de la Torre J; Palao D; Rojo L; Gutiérrez M; Casais L; Riesgo Y
Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
[TBL] [Abstract][Full Text] [Related]
7. Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Gómez Gómez JM; Teixidó Perramón C
J Clin Psychiatry; 2000 Apr; 61(4):285-9. PubMed ID: 10830150
[TBL] [Abstract][Full Text] [Related]
8. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Gründer G; Wetzel H; Schlösser R; Benkert O
Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
[TBL] [Abstract][Full Text] [Related]
9. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
Rudolph RL; Fabre LF; Feighner JP; Rickels K; Entsuah R; Derivan AT
J Clin Psychiatry; 1998 Mar; 59(3):116-22. PubMed ID: 9541154
[TBL] [Abstract][Full Text] [Related]
10. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
Tzanakaki M; Guazzelli M; Nimatoudis I; Zissis NP; Smeraldi E; Rizzo F
Int Clin Psychopharmacol; 2000 Jan; 15(1):29-34. PubMed ID: 10836283
[TBL] [Abstract][Full Text] [Related]
11. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial.
de Montigny C; Silverstone PH; Debonnel G; Blier P; Bakish D
J Clin Psychopharmacol; 1999 Oct; 19(5):401-6. PubMed ID: 10505581
[TBL] [Abstract][Full Text] [Related]
13. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
Costa e Silva J
J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
[TBL] [Abstract][Full Text] [Related]
15. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
Khan A; Upton GV; Rudolph RL; Entsuah R; Leventer SM
J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia.
Benkert O; Gründer G; Wetzel H; Hackett D
J Psychiatr Res; 1996; 30(6):441-51. PubMed ID: 9023787
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.
Bielski RJ; Ventura D; Chang CC
J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045
[TBL] [Abstract][Full Text] [Related]
18. Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group.
Cunningham LA
Ann Clin Psychiatry; 1997 Sep; 9(3):157-64. PubMed ID: 9339881
[TBL] [Abstract][Full Text] [Related]
19. A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.
Diaz-Martinez A; Benassinni O; Ontiveros A; Gonzalez S; Salin R; Basquedano G; Martinez RA
Clin Ther; 1998; 20(3):467-76. PubMed ID: 9663362
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of venlafaxine compared with tricyclic antidepressants in depressive disorder: a meta-analysis.
van den Broek WW; Mulder PG; van Os E; Birkenhäger TK; Pluijms E; Bruijn JA
J Psychopharmacol; 2009 Aug; 23(6):708-13. PubMed ID: 18562424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
